deltatrials
Terminated OBSERVATIONAL NCT01032447

Overcoming Obstacles to Clinical Trials Enrollment Through a Navigator Program

Sponsor: Stanford University

Interventions Navigator Support
Updated 7 times since 2017 Last updated: Sep 26, 2016 Started: Jan 31, 2010 Primary completion: Jan 31, 2011 Completion: Jul 31, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

This observational or N/A phase trial investigates Breast Cancer and Genital Neoplasms, Female and is currently terminated or withdrawn. Stanford University leads this study, which shows 7 recorded versions since 2010 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Apr 2018 · 15 months · monthly snapshotTerminated~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 19 months · monthly snapshotTerminated~Jan 2026 – present · 3 months · monthly snapshotTerminated

Change History

7 versions recorded
  1. Jan 2026 — Present [monthly]

    Terminated

  2. Sep 2024 — Present [monthly]

    Terminated

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated

  5. Jun 2018 — Jan 2021 [monthly]

    Terminated

Show 2 earlier versions
  1. Apr 2018 — Jun 2018 [monthly]

    Terminated

    Phase: NANone

  2. Jan 2017 — Apr 2018 [monthly]

    Terminated NA

    First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Stanford University
Data source: Stanford University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations